New: the Income Securities Screening Form now screens by price, yield, S&P rating, call status and trading volume, and you can save your searches to run again. Try the updated form.
Biohaven Ltd. (BHVN)
BHVN · NYSE · Common · CUSIP G1110E107
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for BHVN and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
G1110E107
IPO
10/21/2022 · 25 Million Shares @ $10.50/share
Prospectus
IPO prospectus »
Business: Biohaven Ltd. is a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies for people with debilitating neurological and neuropsychiatric diseases, including rare disorders.

Company Contact

CEO
Vlad Coric
CFO
Matthew Buten
Headquarters
215 Church Street,New Haven, CT 06510
Phone
203-404-0410
Investor Relations
Jennifer Porcelli · 203-404-0410 · jennifer.porcelli@biohavenpharma.com
SEC EDGAR Filings
View filings »